Michael Brändle

9.1k total citations · 2 hit papers
111 papers, 4.8k citations indexed

About

Michael Brändle is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Michael Brändle has authored 111 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Surgery and 19 papers in Epidemiology. Recurrent topics in Michael Brändle's work include Diabetes Treatment and Management (24 papers), Diabetes Management and Research (23 papers) and Pituitary Gland Disorders and Treatments (13 papers). Michael Brändle is often cited by papers focused on Diabetes Treatment and Management (24 papers), Diabetes Management and Research (23 papers) and Pituitary Gland Disorders and Treatments (13 papers). Michael Brändle collaborates with scholars based in Switzerland, United States and Australia. Michael Brändle's co-authors include William H. Herman, Christoph Schmid, Michael M. Engelgau, Peter Wiesli, Bahman P. Tabaei, Ray Burke, Robert E. Ratner, Ping Zhang, Haiyu Zhou and Nor Azmi Kamaruddin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Michael Brändle

103 papers receiving 4.5k citations

Hit Papers

Liraglutide, a once‐daily human GLP‐1 analogue, added to ... 2005 2026 2012 2019 2009 2005 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU)
    2009 687 citations Michel Marre, Michael Brändle et al. Diabetic Medicine profile →
  2. The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance
    2005 501 citations William H. Herman, Michael Brändle et al. profile →

Peers

Michael Brändle
Danita D. Byrd-Holt United States
Rachel Pessah‐Pollack United States
Michael Doumas Greece
René Rodríguez‐Gutiérrez Mexico
Andrea O. Y. Luk Hong Kong
Ann‐Marie Svensson Sweden
Stephen L. Kopecky United States
Michael Hecht Olsen Denmark
Dipender Gill United Kingdom
Harm R. Haak Netherlands
Danita D. Byrd-Holt United States
Michael Brändle
Citations per year, relative to Michael Brändle Michael Brändle (= 1×) peers Danita D. Byrd-Holt

Countries citing papers authored by Michael Brändle

Since Specialization
Citations

This map shows the geographic impact of Michael Brändle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Brändle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Brändle more than expected).

Fields of papers citing papers by Michael Brändle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Brändle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Brändle. The network helps show where Michael Brändle may publish in the future.

Co-authorship network of co-authors of Michael Brändle

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Brändle. A scholar is included among the top collaborators of Michael Brändle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Brändle. Michael Brändle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleisch, Elgar, et al.. (2024). Digital health technologies for metabolic disorders in older adults: a scoping review protocol. BMJ Open. 14(12). e085797–e085797. 1 indexed citations
2.
Gastaldi, Giacomo, Sébastien Thalmann, Markus Laimer, et al.. (2023). Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023). Swiss Medical Weekly. 153(4). 40060–40060. 15 indexed citations
3.
4.
Renström, Frida, et al.. (2021). Representativeness of the Swiss Diabetes Registry – a single centre analysis. Swiss Medical Weekly. 151(2728). w20525–w20525. 4 indexed citations
5.
Renström, Frida, et al.. (2018). Compliance with guidelines for disease management in diabetes: results from the SwissDiab Registry. BMJ Open Diabetes Research & Care. 6(1). e000454–e000454. 10 indexed citations
6.
Trombetti, Andrea, Emanuel Christ, Christoph Henzen, et al.. (2016). Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms. Journal of Endocrinological Investigation. 39(5). 567–576. 28 indexed citations
7.
Ye, Wen, Michael Brändle, Morton B. Brown, & William H. Herman. (2015). The Michigan Model for Coronary Heart Disease in Type 2 Diabetes: Development and Validation. Diabetes Technology & Therapeutics. 17(10). 701–711. 15 indexed citations
8.
9.
Gerber, Philipp A., Richard A. Zuellig, Oliver Tschopp, et al.. (2015). Glycemia, Hypoglycemia, and Costs of Simultaneous Islet-Kidney or Islet After Kidney Transplantation Versus Intensive Insulin Therapy and Waiting List for Islet Transplantation. Transplantation. 99(10). 2174–2180. 15 indexed citations
10.
Schmid, Sabine, Jürgen Fornaro, Christian Rothermundt, et al.. (2014). Abiraterone—What Is Wrong With the Adrenal Glands?. Clinical Genitourinary Cancer. 12(4). e133–e137. 1 indexed citations
11.
Christ, Emanuel, Damian Wild, Martin Béhé, et al.. (2013). Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. The Lancet Diabetes & Endocrinology. 1(2). 115–122. 135 indexed citations
12.
Steffen, Thomas, René Warschkow, Michael Brändle, Ilaria Tarantino, & Thomas Clerici. (2010). Randomized controlled trial of bilateral superficial cervical plexus blockversusplacebo in thyroid surgery. British journal of surgery. 97(7). 1000–1006. 31 indexed citations
13.
Marre, Michel, Michael Brändle, Nor Azmi Kamaruddin, et al.. (2009). Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU). Diabetic Medicine. 26(3). 268–278. 687 indexed citations breakdown →
14.
Tischler, Verena, et al.. (2009). New onset alopecia and hirsutism in a postmenopausal women. Gynecological Endocrinology. 25(5). 324–327. 12 indexed citations
15.
16.
Pavlicek, Vojtech, et al.. (2006). Inaccurate Self-Monitoring of Blood Glucose Readings in Patients on Chronic Ambulatory Peritoneal Dialysis with Icodextrin. Experimental and Clinical Endocrinology & Diabetes. 114(3). 124–126. 14 indexed citations
17.
Brändle, Michael, Paul Komminoth, Parvin Saremaslani, et al.. (2004). A Novel Succinate Dehydrogenase Subunit B Gene Mutation, H132P, Causes Familial Malignant Sympathetic Extraadrenal Paragangliomas. The Journal of Clinical Endocrinology & Metabolism. 89(1). 362–367. 21 indexed citations
18.
Wiesli, Peter, René L. Bernays, Michael Brändle, et al.. (2004). Effect of pituitary surgery in patients with acromegaly on adiponectin serum concentrations and alanine aminotransferase activity. Clinica Chimica Acta. 352(1-2). 175–181. 18 indexed citations
19.
Wiesli, Peter, Michael Brändle, Sebastian Brandner, Spyros Kollias, & René L. Bernays. (2003). Extensive spherical amyloid deposition presenting as a pituitary tumor. Journal of Endocrinological Investigation. 26(6). 552–555. 15 indexed citations
20.
Wiesli, Peter, et al.. (2003). Impact of thyroid dysfunction on serum cystatin C. Kidney International. 63(5). 1944–1947. 281 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danita D. Byrd-Holt Breakdown of academic impact, for papers by Rachel Pessah‐Pollack Breakdown of academic impact, for papers by Michael Doumas Breakdown of academic impact, for papers by René Rodríguez‐Gutiérrez Breakdown of academic impact, for papers by Andrea O. Y. Luk Breakdown of academic impact, for papers by Ann‐Marie Svensson Breakdown of academic impact, for papers by Stephen L. Kopecky Breakdown of academic impact, for papers by Michael Hecht Olsen Breakdown of academic impact, for papers by Dipender Gill Breakdown of academic impact, for papers by Harm R. Haak
Rankless by CCL
2026